Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference June ...

Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...

PFE currently has a forward P/E ratio of 7.57, while LLY has a forward P/E of 32.57. We also note that PFE has a PEG ratio of 0.84. This metric is used similarly to the famous P/E ratio, but the ...

During the 2022 inflation shock, LLY stock saw a 19% decline, and it fell 23% during the 2020 COVID-19 pandemic market correction. However, when compared to the broader market, ...

Wegovy, which is a prescription medicine is indicated to help manage weight and lower the risk of serious heart-related ...

Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our P/B Growth Investor model based on the published strategy of ...

A first look at the phase 3 data with Eli Lilly's oral GLP-1 agonist orforglipron reveals encouraging blood sugar control ...

We recently published a list of Jim Cramer Had These 21 Stocks on His Radar. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that ...

A caller asked what Cramer’s thoughts on Eli Lilly and Company (NYSE:LLY) were, and he commented: “Okay, Eli Lilly. We bought some just the other day for the Charitable Trust.

First of all, play this short video and just listen. That throaty growl under acceleration is the result of the cold-air intake. It sounds great on this VW VR6, but it was even better on my 1.8T ...

With a trading volume of 1,509,635, the price of LLY is up by 1.2%, reaching $722.3. Current RSI values indicate that the stock is may be approaching oversold.